Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by 4D pharma
Update on Suspension of Trading
June 24, 2022
From
4D pharma
Via
Business Wire
Tickers
LBPS
4D pharma to Present at the H.C. Wainwright Global Investment Conference
May 19, 2022
From
4D pharma
Via
Business Wire
Tickers
LBPS
4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference
May 17, 2022
From
4D pharma
Via
Business Wire
Tickers
LBPS
4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab) for the Treatment of Renal Cell Carcinoma
March 23, 2022
From
4D pharma
Via
Business Wire
Tickers
LBPS
4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit
February 23, 2022
From
4D pharma
Via
Business Wire
Tickers
LBPS
4D pharma Announces Additional Positive Data From Part A of the Phase I/II Trial Of MRx-4DP0004 For the Treatment of Asthma
January 27, 2022
From
4D pharma
Via
Business Wire
Tickers
LBPS
4D pharma to Participate in Jefferies Virtual Next Generation IBD Therapeutics Summit
October 12, 2021
From
4D pharma
Via
Business Wire
Tickers
LBPS
4D pharma to Participate in Upcoming Virtual Investor Conferences in September
September 09, 2021
From
4D pharma
Via
Business Wire
Tickers
LBPS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.